##semicolon##
острый миелобластный лейкоз, ТР – 53 (Arg72Pro), GSTP1 (Ile105Pro), GSTM1 (С/Т), аллели, генотипы, носительство, резистентность, ПХТ.##submission.citations##
Babekir E. A. et al. GSTM1 and GSTT1 polymorphisms and susceptibility to acute myeloid Leukemia: A Case–control Study of the Sudanese Population //Asian Pacific Journal of Cancer Biology. – 2019. – Т. 4. – №. 1. – С. 7–10.
Ch K. Z. et al. Etiopathogenesis of blood cancer development system //Научный Фокус. – 2023. – Т. 1. – №. 3. – С. 181–185.].
De Kouchkovsky I., Abdul–Hay M. Acute myeloid leukemia: a comprehensive review and 2016 update //Blood cancer journal. – 2016. – Т. 6. – №. 7. – С. e441–e441.
Farasani A. Genetic variants of glutathione S–transferase and the risk of acute myeloid leukemia in a Saudi population //Saudi journal of biological sciences. – 2019. – Т. 26. – №. 7. – С. 1525–1530.
Fujita T. C. et al. Acute lymphoid leukemia etiopathogenesis //Molecular Biology Reports. – 2021. – Т. 48. – С. 817–822.
He H. R. et al. Glutathione S–transferase gene polymorphisms and susceptibility to acute myeloid leukemia: meta–analyses //Japanese Journal of Clinical Oncology. – 2014. – Т. 44. – №. 11. – С. 1070–1081.
Megias–Vericat J. E. et al. Pharmacogenetics of metabolic genes of anthracyclines in acute myeloid leukemia //Current drug metabolism. – 2018. – Т. 19. – №. 1. – С. 55–74.
Morita K. et al. Clonal evolution of acute myeloid leukemia revealed by high–throughput single–cell genomics //Nature communications. – 2020. – Т. 11. – №. 1. – С. 5327.
Verma S. et al. Systematic review of epigenetic targets in acute myeloid leukemia //American Journal of Blood Research. – 2021. – Т. 11. – №. 5. – С. 458.
Zhang Q. et al. Molecular and oral manifestations of langerhans cell histiocytosis preceding acute myeloid leukemia //BMC Oral Health. – 2022. – Т. 22. – №. 1. – С. 386.